Medical Properties Trust, Inc. (FRA:M3P)

Medical Properties Trust Statistics

Total Valuation

FRA:M3P has a market cap or net worth of EUR 2.87 billion. The enterprise value is 10.64 billion.

Market Cap	2.87B
Enterprise Value	10.64B

Important Dates

The last earnings date was Friday, February 6, 2026.

Earnings Date	Feb 6, 2026
Ex-Dividend Date	Dec 11, 2025

Share Statistics

Current Share Class	597.01M
Shares Outstanding	n/a
Shares Change (YoY)	+0.11%
Shares Change (QoQ)	-0.03%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	489.80M

Valuation Ratios

Price/FFO Ratio	19.20
Price/AFFO Ratio	n/a
PE Ratio	n/a
Forward PE	71.08
PS Ratio	3.46
PB Ratio	0.73
P/TBV Ratio	0.73
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-44.95
EV / Sales	12.90
EV / EBITDA	13.80
EV / EBIT	19.66
EV / FCF	n/a

Financial Position

The company has a current ratio of 3.73, with a Debt / Equity ratio of 2.10.

Current Ratio	3.73
Quick Ratio	3.39
Debt / Equity	2.10
Debt / EBITDA	11.96
Debt / FCF	n/a
Interest Coverage	1.06

Financial Efficiency

Return on equity (ROE) is -5.85% and return on invested capital (ROIC) is 3.78%.

Return on Equity (ROE)	-5.85%
Return on Assets (ROA)	2.30%
Return on Invested Capital (ROIC)	3.78%
Return on Capital Employed (ROCE)	3.73%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	7.02M
Profits Per Employee	-2.01M
Employee Count	118
Asset Turnover	0.07
Inventory Turnover	n/a

Taxes

In the past 12 months, FRA:M3P has paid 32.89 million in taxes.

Income Tax	32.89M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +5.39% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+5.39%
50-Day Moving Average	4.46
200-Day Moving Average	4.16
Relative Strength Index (RSI)	69.54
Average Volume (20 Days)	846

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	22.43

Income Statement

In the last 12 months, FRA:M3P had revenue of EUR 827.87 million and -236.72 million in losses. Loss per share was -0.39.

Revenue	827.87M
Gross Profit	796.86M
Operating Income	459.73M
Pretax Income	-202.12M
Net Income	-236.72M
EBITDA	690.42M
EBIT	459.73M
Loss Per Share	-0.39

Balance Sheet

The company has 460.65 million in cash and 8.26 billion in debt, with a net cash position of -7.80 billion.

Cash & Cash Equivalents	460.65M
Total Debt	8.26B
Net Cash	-7.80B
Net Cash Per Share	n/a
Equity (Book Value)	3.92B
Book Value Per Share	6.57
Working Capital	1.28B

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross margin is 96.25%, with operating and profit margins of 55.53% and -28.50%.

Gross Margin	96.25%
Operating Margin	55.53%
Pretax Margin	-24.41%
Profit Margin	-28.50%
EBITDA Margin	83.40%
EBIT Margin	55.53%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 0.29, which amounts to a dividend yield of 5.69%.

Dividend Per Share	0.29
Dividend Yield	5.69%
Dividend Growth (YoY)	-32.53%
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.11%
Shareholder Yield	5.59%
Earnings Yield	-8.25%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	3